Obesity

Adults with obesity receiving tirzepatide lost more than 25% of their body weight and were able to maintain their weight loss for up to 88 weeks, according to data from the SURMOUNT-4 trial.

Slow walking pace and weight gain may be linked to chronic kidney disease risk in adults who have obesity but not diabetes, according to a study by Drexel University researchers.

According to CDC data, 22 states had an adult obesity prevalence of 35% or higher in 2022, up from 19 in 2021 and none in 2012.

Hypertension is also known as high blood pressure. It is defined as transitory (short-lived) or chronic elevation of the blood pressure in the arteries. This elevation may lead to cardiovascular damage. When left untreated, the damage to the circulatory system can cause heart attack, stroke, heart failure, heart disease and kidney failure.

PHILADELPHIA — In a small study, more women with obesity reported vasomotor, genitourinary, mood and libido symptoms associated with menopause than their peers without obesity, according to a presenter.

The American Heart Association Scientific Sessions, which will be held live in Philadelphia and can be attended virtually Nov. 10 to 13, will feature eight late-breaking science sessions over 3 days.

By performing physical activities in the mornings or afternoons, adults may lower their risk for developing type 2 diabetes. The same could not be said for those who exercise during the evening.

Surgical outcomes are affected by key factors that orthopedic surgeons assess before and during the episode of care.

With reports of dramatic weight loss achieved using a new generation of diabetes drugs — one FDA approved for weight loss and another with a decision expected this fall — more adults are seeking medical therapy for obesity.

A surge of blockbuster anti-obesity drugs has dramatically changed the landscape for chronic weight management and opened new avenues of research in gastrointestinal and liver disease alongside concerns for potential GI side effects.